# Project State

## Project Reference

See: .planning/PROJECT.md (updated 2026-02-21)

**Core value:** A reliable, end-to-end protein design workflow where a researcher goes from sequence to structure to expert analysis to mutagenesis to report without data loss, silent failures, or manual workarounds.
**Current focus:** Phase 1 - Git & Code Health

## Current Position

Phase: 1 of 8 (Git & Code Health)
Plan: 0 of TBD in current phase
Status: Ready to plan
Last activity: 2026-02-21 — Roadmap created; 28 v1 requirements mapped across 8 phases

Progress: [░░░░░░░░░░] 0%

## Performance Metrics

**Velocity:**
- Total plans completed: 0
- Average duration: -
- Total execution time: 0 hours

**By Phase:**

| Phase | Plans | Total | Avg/Plan |
|-------|-------|-------|----------|
| - | - | - | - |

**Recent Trend:**
- Last 5 plans: -
- Trend: -

*Updated after each plan completion*

## Accumulated Context

### Decisions

Decisions are logged in PROJECT.md Key Decisions table.
Recent decisions affecting current work:

- qwen2.5:14b as default LLM (best quality/fit for 12 GB VRAM)
- Phase 1/Phase 2 mutagenesis split (allows user review before expensive execution) — approval gate not yet enforced, Phase 2 fixes this
- OST comprehensive scoring per mutant flagged for revisit — Phase 3 addresses cap/optional flag

### Pending Todos

None yet.

### Blockers/Concerns

- `mutagenesis_agents.py` is untracked in git — Phase 1 resolves this immediately
- Missing approval gate between mutagenesis Phase 1 and Phase 2 is a live correctness bug — Phase 2 fixes it
- No Phase 1 to Phase 2 integration test — Phase 4 adds it; Phases 2-3 must complete first so there is correct behavior to test

## Session Continuity

Last session: 2026-02-21
Stopped at: Roadmap created; ready to run /gsd:plan-phase 1
Resume file: None
